ImmuCell Corp
NASDAQ:ICCC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Raute Oyj
OMXH:RAUTE
|
FI |
|
N
|
NIQ Global Intelligence PLC
NYSE:NIQ
|
US |
|
R
|
Ravi Kumar Distilleries Ltd
NSE:RKDL
|
IN |
|
Brother Enterprises Holding Co Ltd
SZSE:002562
|
CN |
|
Warehouses de Pauw NV
XBRU:WDP
|
BE |
|
A
|
Anhui Fengyuan Pharmaceutical Co Ltd
SZSE:000153
|
CN |
|
Newcapec Electronics Co Ltd
SZSE:300248
|
CN |
|
I
|
Inmobiliaria San Patricio SA
SGO:ISANPA
|
CL |
|
Zhejiang Sunoren Solar Technology Co Ltd
SSE:603105
|
CN |
|
G
|
Greentown Management Holdings Company Ltd
HKEX:9979
|
CN |
|
M
|
Morris Home Holdings Ltd
HKEX:1575
|
CN |
|
Brenntag SE
XETRA:BNR
|
DE |
ImmuCell Corp
Long-Term Debt
ImmuCell Corp
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
ImmuCell Corp
NASDAQ:ICCC
|
Long-Term Debt
$7.9m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
10%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Long-Term Debt
$58.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
7%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Long-Term Debt
$22.1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
0%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Long-Term Debt
$50B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Long-Term Debt
$106.7m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-18%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Long-Term Debt
$2.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
22%
|
|
ImmuCell Corp
Glance View
ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company is headquartered in Portland, Maine and currently employs 60 full-time employees. The firm is engaged in development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. The company manufactures and markets the First Defense product line for the prevention of scours in newborn dairy and beef calves. The company expanded this line into five different products with formulations targeting E. coli and coronavirus pathogens, as well as E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. These product line provides Immediate Immunity to newborn calves. The firm is engaged in development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. Its products reduce the use of traditional antibiotics in food producing animals.
See Also
What is ImmuCell Corp's Long-Term Debt?
Long-Term Debt
7.9m
USD
Based on the financial report for Dec 31, 2025, ImmuCell Corp's Long-Term Debt amounts to 7.9m USD.
What is ImmuCell Corp's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
10%
Over the last year, the Long-Term Debt growth was -13%. The average annual Long-Term Debt growth rates for ImmuCell Corp have been -5% over the past three years , -2% over the past five years , and 10% over the past ten years .
